How is the Inovio Pharmaceuticals Inc today?

The Inovio Pharmaceuticals Inc today is trading in the down by -6.10% at 2.00.

What is Inovio Pharmaceuticals Inc Annual Revenue?

Inovio Pharmaceuticals Inc Annual Revenue fell 73.83%, in the last year to $0.22 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Inovio Pharmaceuticals Inc Annual Net Profit?

Inovio Pharmaceuticals Inc Annual Net Profit rose 20.62% in the last year to $107.25 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Inovio Pharmaceuticals Inc Price to Earning Ratio?

Inovio Pharmaceuticals Inc Price to Earning Ratio is -0.76, which is negative.

What is Inovio Pharmaceuticals Inc Stock Price?

Inovio Pharmaceuticals Inc Stock Price fell 80.26% and underperformed its sector by 135.73% in the past year.

What is Inovio Pharmaceuticals Inc Quarterly Net profit?

Inovio Pharmaceuticals Inc Quarterly Net profit rose 35.36% YoY to $19.69 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Inovio Pharmaceuticals Inc Debt to Equity Ratio?

Inovio Pharmaceuticals Inc Debt to Equity Ratio of 0.17 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Inovio Pharmaceuticals Inc Return on Equity(ROE)?

Inovio Pharmaceuticals Inc Return on Equity(ROE) for the last financial year was -115.42%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Inovio Pharmaceuticals Inc Mutual Fund Holding?

Inovio Pharmaceuticals Inc Mutual Fund Holding increased by 2.05% in the last quarter to 20.39.

What is Inovio Pharmaceuticals Inc Promoter Share Holding?

Inovio Pharmaceuticals Inc Promoter Share Holding increased by 0.03% in the most recent quarter to 1.68%.

What is Inovio Pharmaceuticals Inc Interest Coverage Ratio?

Inovio Pharmaceuticals Inc Interest Coverage Ratio is -602.12, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Inovio Pharmaceuticals Inc Institutional Holding?

Inovio Pharmaceuticals Inc Institutional Holding decreased by 0.58% in the last quarter to 36.29.

Inovio Pharmaceuticals Inc XNAS: INO

Inovio Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Inovio Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Inovio Pharmaceuticals Inc
Rating: 1.31641675
Author: Trendlyne DVM scores

about

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The compa...

2.00 -0.13 (-6.10%)

83.78% Fall from 52W High

467.0K XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

11.7 / 100

Technically Neutral

41.0 / 100

8

1Yr Price target upside is 300%

5 analysts

Inovio Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Inovio Pharmaceuticals Inc FAQ

How is Inovio Pharmaceuticals Inc today?

Inovio Pharmaceuticals Inc today is trading in the red, and is down by -6.10% at 2.00.

How has Inovio Pharmaceuticals Inc performed historically?

Inovio Pharmaceuticals Inc is currently trading down -6.10% on an intraday basis. In the past week the stock rose 1.52%. stock has been up 1.01% in the past quarter and fell -80.26% in the past year. You can view this in the overview section.